Christine A. Poon
Board Member
Regeneron Pharmaceuticals, Inc. (REGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Christine A. Poon
Christine A. Poon is recorded as Board Member at Regeneron Pharmaceuticals, Inc. (REGN). Regeneron Pharmaceuticals, Inc. reported in an 8-K filed April 17, 2023 that Christine A. Poon was appointed Lead Independent Director of the Board.
“Effective upon the expiration of Dr. Vagelos’s term, the Board plans to elect Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of the Company, and George D. Yancopoulos, M.D., Ph.D., President and Chief Scientific Officer of the Company, as Co-Chairs of the Board (in addition to Dr. Schleifer’s and Dr. Yancopoulos’s continued roles as President and Chief Executive Officer and President and Chief Scientific Officer, respectively) and to designate Christine A. Poon as the Lead Independent Director of the Board.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2020-06-12–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Regeneron Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- George D. Yancopoulos, M.D., Ph.D. Chairman
- Leonard S. Schleifer, M.D., Ph.D. Chairman
- Joseph J. LaRosa General Counsel
- Craig B. Thompson, M.D. Board Member
- David P. Schenkein Board Member
- David P. Schenkein, M.D. Board Member
- Huda Y. Zoghbi, M.D. Board Member
- Joseph L. Goldstein, M.D. Board Member
- Kathryn Guarini Board Member
- Kathryn Guarini, Ph.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.